Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 1 - 20 of 86
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Nov 2012, 8:32 am by fraudfighters
This settlement was with pharmaceutical giant Boehrigner Ingelheim Pharmaceuticals Inc.  [read post]
8 May 2016, 9:59 pm by Patent Docs
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
1 Feb 2007, 4:56 pm
The government announced that it was joining a qui tam lawsuit under the False Claims Act against the company Boehringer Ingelheim Roxane, Inc. [read post]
26 Oct 2012, 4:31 am by Ben Vernia
According to DOJ’s press release: Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD) drugs Atrovent and Combivent, and the hypertension drug Micardis, the Justice Department announced today. [read post]
1 Jan 2018, 9:46 am
AUSTIN – Texas Attorney General Ken Paxton, along with attorneys general from all other states and the District of Columbia, have reached a $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc. in a complaint over alleged off-label marketing and deceptive claims about four of its prescription drugs. [read post]
3 Jun 2014, 4:41 pm
That same year, Boehringer Ingelheim Pharmaceuticals, Inc. made $1.5 billion in sales of Pradaxa. [read post]
8 Jul 2012, 9:13 pm by Patent Docs
Prism C.V. • Defendants: Roxane Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. [read post]
22 Mar 2012, 1:15 pm by Tom Lamb
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com)  Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran.   [read post]
2 May 2013, 10:30 am by Amanda Greenburg
On March 26, 2013, Plaintiff Lisa Mulhall filed a claim in the Illinois Southern District Court against the manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for causing her mother’s death. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 9:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 12:42 pm
Two more plaintiffs have come forward seeking drug injury compensation from Boehringer Ingelheim Pharmaceuticals Inc. for the harm they have suffered from taking Pradaxa. [read post]
26 Dec 2012, 1:35 pm by Tom Lamb
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa  (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]